Organizational Chart

Departmental Flow Chart

EXECUTIVE COMMITTEE

The CBB Executive Committee is composed of representatives from eight university departments. It is the primary policy-making group of the CBB and meets regularly to discuss and advise on budgets as well as research and educational programs. CBB members in their respective departments elect representatives of the Executive Committee annually and they may serve a three-year period or more.

Current CBB Executive Committee
Faculty Member Department
Mark Arnold,
Ph.D.
(Chair)
Chemistry/ Center for Biocatlaysis and Bioprocessing
Christopher Ahern,
Ph.D.
Biosciences
Charles Brenner,
Ph.D.
Biochemistry
Robert Kerns,
Ph.D.
Pharmaceutical Sciences and Experimental Therapeutics
Amnon Kohen,
Ph.D.
Chemistry
Tim Mattes,
Ph.D.
Civil & Environmental Engineering
Eric Nuxoll,
Ph.D.
Chemical & Biochemical Engineering
Chioma Okeoma,
Ph.D.
Microbiology
Tonya Peeples,
Ph.D.
Chemical & Biochemical Engineering
Dan Quinn,
Ph.D.
Chemistry
Michael Schultz,
Ph.D.
Radiology
Justine Delagro Trainee
Kyle Powers Trainee

EXTERNAL ADVISORY BOARD

The CBB Advisory Board consists of distinguished academic and industrial scientists representing agrochemical, pharmaceutical, chemical and biotechnology industry. Board members attend the annual CBB conference to discuss the direction of the Center, its programs, and offer insights into ways the Center can best interact with industries through technology transfer. Board members also recommend topics for the annual conference, and sometimes serve as speakers.

Advisory Board
Board Members Affiliation
Charles Abbas, Ph.D. Director of Yeast and Renewable Research, Archer Daniels Midland
Mark A. Behlke, M.D., Ph.D. Chief Scientific Officer, Integrated DNA Technologies, Inc.
Peter Mueller, Ph.D. President, The Mueller Health Foundation
Richard Whitaker, Ph.D. Pharma/Biotech Consultant
Debbie Yaver, Ph.D. Plant Director & Director of Production Strain Technology, Novozyme, Inc. 

 

Past Board Members
  Affiliation - current at time of posting and may not reflect their current position/affiliation
Thomas Binder President, ADM Research Division Archer Daniel Midland Company
Douglas Cameron Chief Scientist, Biotechnology Development Center, Cargill Inc.
Arnold Demain Charles A Dana Research Institute, Drew University, National Academy of SciencesMember
Robert DiCosimo Senior Research Fellow, DuPont Central Research and Development
Mervyn de Souza Director of Technology and Innovation, BioPharma and Savory Flavors, Sensient Technologies
Randolph Greasham Director of Process Research, Merck
Steven J. Gould Chief Scientific Officer, Mera Pharmaceuticals
Lorenz Hasler Senior Project Evaluation Manager, Globial Biological Operations, Lonza AG
T. Kent Kirk Forest Products Fed Res. Labs, Dept Bacteriology, University of Wisconsin, Madison, Member National Academy of Sciences
Hans Leuenberger Deputy Director, Central Research, Hoffmann LaRoche
Ashwin Madia Vice President for Biotechnology research, Cargill
Barry Marrs Director of Biotechnology, Hercules
Ellen L. McCormick Director, Pfizer Global Biologics
Saul Neidleman Neidleman Consulting
Peder Holk Nielsen Corporate Vice president for Enzyme Development & Industrial Biotechnology, Novo Nordisk
Ramesh N. Patel Process Research and Development, Bristol Myers Squibb
Nancy Platt Vice President for Research, Pioneer HiBred
Rolland Poust Director, Pharmaceutical Service, The University of Iowa
Karl Sanford Vice President for Technology Development, Genencor International
Jim Spain Air Force Research Laboratory, MLQL, Tyndall Air Force Base
Mani Subramanian Director, Biotechnology Division, Dow Chemical Company
Tim Tressel Director, Process and Analytical Sciences, Amgen, Inc.
Susan Truesdell Central Research and Development, Pfizer Inc.
Mickey Wells Director, Pharmaceutical Service, The University of Iowa
James F White Senior Research Associate, Engelhard Corporation
Gregg Whited Genencor International
Vincent Witterholt Fellow and Distinguished Scientist, DuPont
Debbie Yaver  Director, Novozymes, Inc.
Milton Zmijewski

Head, Biocatalysis Research, Eli Lilly